Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Adenoma × Octreotide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neuroendocrine Tumors 4 Neoplasms 2 Acromegaly 2 Serotonin Syndrome 1 Pituitary Neoplasms 1 Pancreatitis 1 Pancreatic Intraductal Neoplasms 1 Gastro-enteropancreatic neuroendocrine tumor 1 Fistula 1 Duodenal Neoplasms 1 Diarrhea 1 Colorectal Neoplasms 1 Carcinoid Tumor 1 Breast Neoplasms 1 Brain Neoplasms 1 Adenoma 1

Interventions

Sunitinib 1 Octreotide 1 Indocyanine Green 1 Drug Evaluation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02032784 2020-07-16

Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding

AdventHealth

Phase 4 Terminated

Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡